Results 11 to 20 of about 286,536 (215)
Background B‐cell chronic lymphocytic leukemia (B‐CLL) is characterized by the expansion of CD5+ malignant B lymphocytes. Recent discoveries have shown that double‐negative T (DNT) cells, double‐positive T (DPT) cells, and natural killer T (NKT)‐cells ...
Luciana Valvano +11 more
doaj +1 more source
Cancer immunotherapy has emerged as a mainstream therapy option in the battle against cancer. Pre-clinical data demonstrates the ability of immunotherapy to harness the immune system to fight disseminated malignancy.
Arta Monir Monjazeb +5 more
doaj +1 more source
Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance. [PDF]
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Tiwary K, Bravo-Cordero JJ.
europepmc +2 more sources
Immune surveillance as a pharmacological target in the early stages of cancer [PDF]
Hongfei Jiang +5 more
doaj +2 more sources
Local Antigen Encounter Is Essential for Establishing Persistent CD8+ T-Cell Memory in the CNS
While the brain is considered an immune-privileged site, the CNS may nevertheless be the focus of immune mediated inflammation in the case of infection and certain autoimmune diseases, e.g., multiple sclerosis. As in other tissues, it has been found that
Amalie S. Schøller +4 more
doaj +1 more source
Human surfactant protein D (SP-D) is a potent innate immune molecule, which is emerging as a key molecule in the recognition and clearance of altered and non-self targets.
Anuvinder Kaur +5 more
doaj +1 more source
Life expectancy has drastically increased over the last few decades worldwide, with important social and medical burdens and costs. To stay healthy longer and to avoid chronic disease have become essential issues.
Roula Khalil +2 more
doaj +1 more source
The role of the tumor microenvironment in leukemias and lymphomas is well established, yet the intricacies of how the malignant cells regulate and influence their non-malignant counterparts remain elusive.
Christine E. Cutucache, Tyler A. Herek
doaj +1 more source
Matrilysin [MMP-7] Expression Selects for Cells with Reduced Sensitivity to Apoptosis
The matrix metalloproteinase matrilysin (MMP-7) has been demonstrated to contribute to tumor development. We have shown previously that members of the TNF family of apoptosis-inducing proteins are substrates for this enzyme, resulting in increased death ...
Barbara Fingleton +3 more
doaj +1 more source
These last 20 years, research on immune tumor microenvironment led to identify some critical recurrent mechanisms used in cancer to escape immune response. Through immune checkpoints, which are cell surface molecules involved in the immune system control,
Quentin Lemasson +7 more
doaj +1 more source

